Luescher et al. found that measuring NSE levels on the third day after a patient admission to an intensive care unit (ICU) improved clinical risk scores (the out-of-hospital cardiac arrest score and the Cardiac Arrest Hospital Prognosis Score—CAHP) for predicting the outcomes of cardiac arrest patients in terms of neurological outcomes and in-hospital mortality [13]. The gene discussed is ENO2; the disease is cardiac arrest.